| Literature DB >> 26869642 |
Ute Woehlbier1, Alicia Colombo2, Mirva J Saaranen3, Viviana Pérez4, Jorge Ojeda4, Fernando J Bustos5, Catherine I Andreu6, Mauricio Torres6, Vicente Valenzuela7, Danilo B Medinas7, Pablo Rozas6, Rene L Vidal8, Rodrigo Lopez-Gonzalez9, Johnny Salameh9, Sara Fernandez-Collemann10, Natalia Muñoz8, Soledad Matus8, Ricardo Armisen11, Alfredo Sagredo11, Karina Palma6, Thergiory Irrazabal6, Sandra Almeida9, Paloma Gonzalez-Perez9, Mario Campero12, Fen-Biao Gao9, Pablo Henny10, Brigitte van Zundert5, Lloyd W Ruddock3, Miguel L Concha13, Juan P Henriquez4, Robert H Brown14, Claudio Hetz15.
Abstract
Disturbance of endoplasmic reticulum (ER) proteostasis is a common feature of amyotrophic lateral sclerosis (ALS). Protein disulfide isomerases (PDIs) areERfoldases identified as possibleALSbiomarkers, as well as neuroprotective factors. However, no functional studies have addressed their impact on the disease process. Here, we functionally characterized fourALS-linked mutations recently identified in two majorPDIgenes,PDIA1 andPDIA3/ERp57. Phenotypic screening in zebrafish revealed that the expression of thesePDIvariants induce motor defects associated with a disruption of motoneuron connectivity. Similarly, the expression of mutantPDIs impaired dendritic outgrowth in motoneuron cell culture models. Cellular and biochemical studies identified distinct molecular defects underlying the pathogenicity of thesePDImutants. Finally, targetingERp57 in the nervous system led to severe motor dysfunction in mice associated with a loss of neuromuscular synapses. This study identifiesERproteostasis imbalance as a risk factor forALS, driving initial stages of the disease.Entities:
Keywords: ERp57; PDIA1; amyotrophic lateral sclerosis; protein disulfide isomerase
Mesh:
Substances:
Year: 2016 PMID: 26869642 PMCID: PMC4972141 DOI: 10.15252/embj.201592224
Source DB: PubMed Journal: EMBO J ISSN: 0261-4189 Impact factor: 11.598